The Securities and Exchange Commission today announced settled charges against Zymergen Inc., an Emeryville, California-based biotechnology company, for misleading IPO investors about its overall market potential, revenue prospects, and customer pipeline… Read More
Related Posts
SEC Charges Advisory Firm Macquarie Investment Management Business Trust with Fraud
The Securities and Exchange Commission today announced registered investment adviser Macquarie Investment Management Business Trust (MIMBT) will pay a total of $79.8 million to settle… BronSEC Charges Advisory Firm Macquarie Investment Management Business Trust with Fraud
SEC Charges Advisory Firm Inspire Investing With Misleading Investors Regarding its Investment Strategy
The Securities and Exchange Commission today charged Idaho-based investment adviser Inspire Investing LLC with making misleading statements and for compliance failures related to the execution… BronSEC Charges Advisory Firm Inspire Investing With Misleading Investors Regarding its Investment Strategy
SEC Charges DeFi Platform Rari Capital and its Founders With Misleading Investors and Acting as Unregistered Brokers
The Securities and Exchange Commission today announced settled charges against Rari Capital, Inc., a supposed decentralized finance (DeFi) protocol, and its co-founders, Jai Bhavnani, Jack… BronSEC Charges DeFi Platform Rari Capital and its Founders With Misleading Investors and Acting as Unregistered Brokers